Where has the world reached in developing a vaccine for coronavirus?

Dr.. Osama Abu Al-Rub

The number of newly infected Coronavirus (Covid-19) in the world has exceeded 620,000, and deaths have exceeded 28,000, so where have scientists arrived in developing virus testing tools, and also developing a vaccine?

The start of the scan tools are tests that are done for people suspected of having the Coronavirus, and are intended to diagnose whether they are infected.

As for the vaccine, it is a product that is given to the person to form immunity in his body against a specific disease, and it consists of disease germs (bacteria or viruses) that have been killed or weakened, and when entering the body it stimulates the immune system to form antibodies to a specific disease and immune memory, so that the microbe immune system remembers The nurse will attack and eliminate it immediately when it enters the body the next time.

In this report, we review the latest developments on developing HIV tests and vaccines:

World Health Organization
The president of the organization, Tedros Adhanom Gebresus, said in a press conference via closed-circuit television in the Swiss city of Geneva, that the creation of the Corona vaccine will take at least 12-18 months.

He explained that the lack of medical protective equipment poses the greatest threat to joint international efforts to save people's lives.

While the development of a safe vaccine is still undergoing appropriate testing and needs at least 12 to 18 months, Gypressus indicated that tests are under way to find drugs that can be used to treat the infected.

He stated that there are patients from Norway and Spain who are among the first to decide to submit to what the organization described as a solidarity test during which the safety and effectiveness of four different types of drugs or combinations of drugs will be compared.

He explained that more than 45 countries participate in the test and the more countries join, "we will get faster results."

America
In the United States, the FDA has agreed to use a new corona virus screening test to obtain results after fifteen minutes.

The inspection company Abbot said it plans to distribute fifty thousand tests per day, starting next week.

The tests will be conducted through light and portable devices that the company manufactures and can be quickly transferred to the areas most affected by the virus. The company expects to produce five million tests every month.

The new examination is the fastest in terms of showing results approved by the US Food and Drug Administration.

Germany
In Germany, the Max Planck Institute will test hospitals for a new vaccine to determine its effectiveness in fighting the Corona virus, and this vaccine was originally innovative against tuberculosis.

Researchers in the Department of Infection Biology at the German Max Planck Institute for Scientific Research are seeking to verify the effectiveness of a serum devised by researchers at the institute called "VPM1002" in protecting against infection with the Corona virus.

And the test will be conducted for the effectiveness of the vaccine in several hospitals in Germany on a group of elderly people, as well as workers in the health services sector, after discussing the matter with the competent authorities.

These two groups were specifically chosen as being at the highest risk of developing new Coronavirus, according to the Max Planck Institute website.

The institute seeks, through the experience of the vaccine designed to protect against tuberculosis, to provide a temporary solution until a vaccine is reached to prevent coronavirus infection.

The increased serum activity and its high level of use safety give hope that it will also be able to alleviate the symptoms of infection with the SK virus.

A study of more than 100 thousand
In Germany, too, a study will be launched on more than 100,000 people to see if they have developed immunity against the emerging corona virus to allow assessment of the spread of the virus, said a spokeswoman for the main institute in charge of its implementation.

Susan Telet of the Helmholtz Center for Infectious Diseases Research in Braunschweig confirmed the information reported by the weekly magazine "Spiegel", according to which the study expected to be launched next April will be based on blood samples extracted from more than one hundred thousand people at regular intervals.

The researchers will analyze whether these samples will secrete Covid-19 antibodies as evidence that the owner has contracted the disease and recovered from it.

Gerard Cruz, who heads the epidemiology department at the Helmoltz Center, told Der Spiegel that “something like a vaccine book can be given to people who have become immune, which allows them to resume their work even with continued restrictions” of movement.

In addition to this institute, the study will be carried out in cooperation with the Robert Koch Institute for Health Monitoring and the Institute of Epidemiology at the Charette Hospital in Berlin. By doing this, scientists seek to determine the extent of the epidemic and the number of deaths caused by infection.

The results of the study, which has not yet been finalized by the date of its commencement, will facilitate the decision-making process regarding the reopening of schools or allowing the organization of major events, etc.

The same source said that preliminary results may be available at the end of next April.

According to the magazine "Der Spiegel" researchers hope that "more accurate testing will be available within two or three months."

Russia
On Friday, the Russian Biomedical Agency said it had developed seven prototypes for vaccines against the Corona virus.

Veronica Skoretsova, director of the agency, in its English language, quoted the agency as saying, "To date, the Russian Biomedical Agency has developed seven genetically engineered vaccine models that have been collected from compact proteins, each containing antigenic determinants (antigen) that is, parts that interact with The virus. "

She added that the current task is to choose the most effective vaccine model from the seven models.

She added that the vaccine that will be ready will not be available before 11 months, noting that the scientists intend to complete all the tests by next July, then move on to the preclinical experiments and "we plan to reach the first and second stage by the end of this year or the first quarter of Next year, "she says.

Iran
An Iranian Ministry of Health official has announced that an Iranian company has produced equipment or devices for testing and testing the Corona virus, and these products have been put on the market.

The director of the Technology Development Center at the Iranian Ministry of Health, Hossein Watanpour added that the new equipment was evaluated at the Iranian Pasteur Institute and licenses were issued to launch it in the markets, noting that in the first stage twenty thousand of these equipment were produced to check the Corona virus and that the Iranian company has the capabilities To export this equipment to other countries.

Turkey
Aegean University in Izmir, western Turkey, has started a project to develop a local vaccine against the Corona virus. The university president, Professor Necdet Bodak, said in a statement on Friday that no licensed vaccine against the virus has yet been found in the world.

He pointed out that efforts are underway in many countries to reach a vaccine against the deadly virus.

He explained that they had formed a team of scientists within the university's drug development center, to carry out research to develop a DNA vaccine against corona with local potential.

He stated that the scientific team started work on the vaccine project, after a series of researches, discussions, and preliminary scenarios on what can be done to counter this virus.

On Tuesday, Turkish Health Minister Fakhruddin Kuja said that his ministry had started a campaign to support the country's scientific sector with the aim of developing a vaccine against the Corona virus.